EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis

Amin Tajerian, Ali Pourvali, Maryam Khoshkhui, Mehraneh Movahedi Aliabadi, Mahya Mobinikhaledi, Arezoo Faridzadeh iD

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03629-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Amin Tajerian und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Arak University of Medical Sciences, Arak, Iran. Hauptthemen laut MEDLINE: Omalizumab, Chronic Urticaria, Cost-Benefit Analysis. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmalizumabChronic UrticariaCost-Benefit AnalysisHumansTreatment OutcomeAnti-Allergic AgentsRandomized Controlled Trials as TopicQuality of Life

Stichwörter der Autor:innen

Chronic urticariaCost-effective treatmentHealthcare affordabilityNetwork meta-analysisOmalizumab

Substanzen

OmalizumabAnti-Allergic Agents

Autor:innen und Institutionen

  • School of Medicine, Arak University of Medical Sciences, Arak, Iran.
  • Department of Pediatrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
  • Department of Allergy and Clinical Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Allergy and Clinical Immunology, Mashhad University of Medical Sciences, Mashhad, Iran. faridzadeha2@mums.ac.ir.

ORCID-Profile: Arezoo Faridzadeh

Zitieren

APA

Tajerian, A., Pourvali, A., Khoshkhui, M., Movahedi Aliabadi, M., Mobinikhaledi, M., & Faridzadeh, A. (2024). Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03629-2

Vancouver

Tajerian A, Pourvali A, Khoshkhui M, Movahedi Aliabadi M, Mobinikhaledi M, Faridzadeh A. Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03629-2

BibTeX
@article{Tajerian2024,
  author = {Tajerian, Amin and Pourvali, Ali and Khoshkhui, Maryam and Movahedi Aliabadi, Mehraneh and Mobinikhaledi, Mahya and Faridzadeh, Arezoo},
  title = {Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03629-2}
}
Kostenlos starten →